Living mini-tumors (organoids) for breast and pancreatic cancer research

Core B: Organoid Biobank

NIH-funded research Cold Spring Harbor Laboratory · NIH-11294230

They grow tiny 3-D tumor models from patient samples to help researchers develop better treatments for breast and pancreatic cancers.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionCold Spring Harbor Laboratory NIH-funded
Lab location1 site (Cold Spring Harbor, United States)
Project IDNIH-11294230 on NIH RePORTER

What this research studies

If you donate tumor tissue, they grow tiny 3-D "mini-organ" tumors in the lab that mimic real cancers. Each organoid is genetically and transcriptomically profiled and classified into molecular subtypes. The biobank collects hundreds of these models, with a focus on basal-subtype breast and pancreatic cancers, and shares them with researchers working on related projects. That lets researchers test drugs and study tumor behavior in living human-derived models that often reflect patient tumors better than older cell lines.

Who could benefit from this research

Good fit: Ideal candidates are people with breast or pancreatic tumors, especially basal-subtype cancers, who can donate fresh tumor tissue during surgery or biopsy.

Not a fit: Patients without available tumor tissue to donate, those with cancer types not represented in the biobank, or those seeking immediate treatment changes are unlikely to gain direct benefit from participating.

Why it matters

Potential benefit: This could enable more personalized drug testing and help identify treatments that work better for specific breast and pancreatic tumor subtypes.

How similar studies have performed: Other organoid biobanks have successfully mirrored human tumor biology and aided preclinical drug testing, though direct translation to patient care is still developing.

Where this research is happening

Cold Spring Harbor, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agents
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.